Advertisement

Topics

FDA approves new standard of care for kidney cancer

20:00 EDT 16 Apr 2018 | AAAS

(UT Southwestern Medical Center) The US Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer.

Original Article: FDA approves new standard of care for kidney cancer

NEXT ARTICLE

More From BioPortfolio on "FDA approves new standard of care for kidney cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...